A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
Primary Purpose
Sleep
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Care2Sleep
Sleep Education
Sponsored by
About this trial
This is an interventional supportive care trial for Sleep focused on measuring Dementia, Caregivers
Eligibility Criteria
Inclusion Criteria for Patients
- Have a diagnosis of Alzheimer's disease (probable or possible) or other related dementia as documented in an electronic medical record
- Community-dwelling
- >1 sleep problems >3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale, - - Aged >60 years
- Have no untreated sleep disorders (e.g., sleep apnea, restless legs syndrome)
- Able to ambulate with or without assistive devices (i.e., dyads will be excluded if the care recipient is bedbound)
- Have no severe medical conditions with a life expectancy of less than 6 months
- Have an eligible caregiver
Inclusion Criteria for Caregivers
- Live with an eligible patient
- Aged >18 years
- Is related to the patient as a family member, a significant other, or a friend
- Have regularly assisted patient with >1 of 6 basic activities of daily living (ADLs; i.e., bathing, dressing, toileting, transferring, continence, feeding) or >1 of 8 Instrumental ADL (IADLs; i.e., using the telephone, shopping, food preparation, housekeeping, laundry, transportation, taking medications, managing money) for the past 6 months
- Pittsburgh Sleep Quality Index (PSQI) total score >5
- Montreal Cognitive Assessment (MoCA) ≥23
- Can communicate in English
Exclusion Criteria:
- Patients will be excluded if they are bedbound or have severe medical conditions with a life expectancy of less than 6 months.
- Paid, professional caregivers will also be excluded.
- If the eligibility criteria for either a patient or a caregiver are not met, the dyads will be excluded for this study.
Sites / Locations
- University of California San DiegoRecruiting
- University of California Los AngelesRecruiting
- Veterans Affairs Greater Los Angeles Healthcare SystemRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Placebo Comparator
Arm Label
In-Person Care2Sleep
Telehealth Care2Sleep
Sleep Education only
Arm Description
In-person, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
Telehealth, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
In-person, education on sleep, aging, and dementia but without specific or individualized recommendations
Outcomes
Primary Outcome Measures
Sleep efficiency-Actigraphy
Nighttime sleep efficiency (i.e., mean percent of time in bed spent asleep) will be calculated from 7 days of wrist actigraphy for patients and caregivers. Range from 0 to 100% with a higher percent indicating better objective sleep quality
Pittsburgh Sleep Quality Index score
Self-reported sleep quality over the past week for patients (reported by caregivers) and caregivers. Range from 0 to 21 with lower scores indicating better subjective sleep quality.
Secondary Outcome Measures
Total score of Revised Memory and Behavior Problem Checklist
Dementia-related problem behaviors among persons with dementia (reported by caregivers). Range from 0 to 96 with higher scores indicating more severe dementia-related behaviors.
Total score of Quality of Life-Alzheimer's Disease Scale
Quality of life among persons with dementia reported by either caregivers or persons with dementia. Range from 4 to 52 with higher scores indicating better quality of life among persons with dementia
Total score of Zarit Burden Interview
Perceived levels of caregiving burden. Range from 0 to 88 with higher scores indicating greater burden among caregivers
Total score of Center for Epidemiological Study of Depression Scale
Perceived frequency of depressive symptoms during the past week. Ranges from 0 to 60 with higher scores indicating greater levels of depressive symptoms among caregivers
Patient-Reported Outcomes Measurement Information System (PROMIS) global health score
Self-reported physical and mental health scores among caregivers. A T-score of 50 represents the mean of the general population. Higher scores indicate better physical and mental health among caregivers
Levels of inflammatory markers
Three key inflammatory markers including C-reactive protein, Tumor necrosis factor-alpha, Interleukin-6 will be collected among caregivers only
Full Information
NCT ID
NCT05452031
First Posted
July 1, 2022
Last Updated
February 22, 2023
Sponsor
University of California, Los Angeles
Collaborators
University of California, San Diego, VA Greater Los Angeles Healthcare System
1. Study Identification
Unique Protocol Identification Number
NCT05452031
Brief Title
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
Official Title
A Dyadic Approach to Improve Sleep and Well-Being Among Persons With Alzheimer's Disease and Their Caregivers
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 30, 2022 (Actual)
Primary Completion Date
January 31, 2027 (Anticipated)
Study Completion Date
May 31, 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
University of California, San Diego, VA Greater Los Angeles Healthcare System
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants will be randomly assigned to in-person Care2Sleep, telehealth Care2Sleep, or to an in-person education control group. The Care2Sleep programs and the control education program will consist of five sessions. The intervention and control programs will begin after baseline assessment and randomization. Posttreatment assessments will be performed immediately after the last session and at 6-month follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep
Keywords
Dementia, Caregivers
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
420 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
In-Person Care2Sleep
Arm Type
Experimental
Arm Description
In-person, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
Arm Title
Telehealth Care2Sleep
Arm Type
Active Comparator
Arm Description
Telehealth, manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
Arm Title
Sleep Education only
Arm Type
Placebo Comparator
Arm Description
In-person, education on sleep, aging, and dementia but without specific or individualized recommendations
Intervention Type
Behavioral
Intervention Name(s)
Care2Sleep
Intervention Description
A multicomponent behavioral sleep program, consisting of sleep hygiene, stimulus control, sleep compression, pleasurable activity, daily walking, and light exposure.
Intervention Type
Behavioral
Intervention Name(s)
Sleep Education
Intervention Description
This group will receive information about sleep, aging, and dementia, but without specific or individualized recommendations
Primary Outcome Measure Information:
Title
Sleep efficiency-Actigraphy
Description
Nighttime sleep efficiency (i.e., mean percent of time in bed spent asleep) will be calculated from 7 days of wrist actigraphy for patients and caregivers. Range from 0 to 100% with a higher percent indicating better objective sleep quality
Time Frame
Change from Baseline Sleep Efficiency at 6 months
Title
Pittsburgh Sleep Quality Index score
Description
Self-reported sleep quality over the past week for patients (reported by caregivers) and caregivers. Range from 0 to 21 with lower scores indicating better subjective sleep quality.
Time Frame
Change from Baseline Pittsburgh Sleep Quality Index score at 6 months
Secondary Outcome Measure Information:
Title
Total score of Revised Memory and Behavior Problem Checklist
Description
Dementia-related problem behaviors among persons with dementia (reported by caregivers). Range from 0 to 96 with higher scores indicating more severe dementia-related behaviors.
Time Frame
Immediately AND 6 months after the last session of the intervention
Title
Total score of Quality of Life-Alzheimer's Disease Scale
Description
Quality of life among persons with dementia reported by either caregivers or persons with dementia. Range from 4 to 52 with higher scores indicating better quality of life among persons with dementia
Time Frame
Immediately AND 6 months after the last session of the intervention
Title
Total score of Zarit Burden Interview
Description
Perceived levels of caregiving burden. Range from 0 to 88 with higher scores indicating greater burden among caregivers
Time Frame
Immediately AND 6 months after the last session of the intervention
Title
Total score of Center for Epidemiological Study of Depression Scale
Description
Perceived frequency of depressive symptoms during the past week. Ranges from 0 to 60 with higher scores indicating greater levels of depressive symptoms among caregivers
Time Frame
Immediately AND 6 months after the last session of the intervention
Title
Patient-Reported Outcomes Measurement Information System (PROMIS) global health score
Description
Self-reported physical and mental health scores among caregivers. A T-score of 50 represents the mean of the general population. Higher scores indicate better physical and mental health among caregivers
Time Frame
Immediately AND 6 months after the last session of the intervention
Title
Levels of inflammatory markers
Description
Three key inflammatory markers including C-reactive protein, Tumor necrosis factor-alpha, Interleukin-6 will be collected among caregivers only
Time Frame
Immediately AND 6 months after the last session of the intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for Patients
Have a diagnosis of Alzheimer's disease (probable or possible) or other related dementia as documented in an electronic medical record
Community-dwelling
>1 sleep problems >3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale, - - Aged >60 years
Have no untreated sleep disorders (e.g., sleep apnea, restless legs syndrome)
Able to ambulate with or without assistive devices (i.e., dyads will be excluded if the care recipient is bedbound)
Have no severe medical conditions with a life expectancy of less than 6 months
Have an eligible caregiver
Inclusion Criteria for Caregivers
Live with an eligible patient
Aged >18 years
Is related to the patient as a family member, a significant other, or a friend
Have regularly assisted patient with >1 of 6 basic activities of daily living (ADLs; i.e., bathing, dressing, toileting, transferring, continence, feeding) or >1 of 8 Instrumental ADL (IADLs; i.e., using the telephone, shopping, food preparation, housekeeping, laundry, transportation, taking medications, managing money) for the past 6 months
Pittsburgh Sleep Quality Index (PSQI) total score >5
Montreal Cognitive Assessment (MoCA) ≥23
Can communicate in English
Exclusion Criteria:
Patients will be excluded if they are bedbound or have severe medical conditions with a life expectancy of less than 6 months.
Paid, professional caregivers will also be excluded.
If the eligibility criteria for either a patient or a caregiver are not met, the dyads will be excluded for this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yeonsu Song
Phone
310-983-3029
Email
ysong@sonnet.ucla.edu
Facility Information:
Facility Name
University of California San Diego
City
La Jolla
State/Province
California
ZIP/Postal Code
92093
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brent Mausbach, PhD
Phone
858-822-7529
Email
bmausbach@health.ucsd.edu
Facility Name
University of California Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yeonsu Song, PhD
First Name & Middle Initial & Last Name & Degree
Yeonsu Song, PhD
Facility Name
Veterans Affairs Greater Los Angeles Healthcare System
City
Los Angeles
State/Province
California
ZIP/Postal Code
91343
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yeonsu Song, PhD
Phone
818-891-7711
Ext
36069
First Name & Middle Initial & Last Name & Degree
Yeonsu Song, PhD
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Materials generated under the project will be disseminated in accordance with policies at UCLA and NIH. Data products from this study will be made available without cost to researchers, students, and analysts. The final database (both GAD and LAD) will be managed at the UCLA School of Nursing Research Office Design & Data Core. User registration will be required through the Design & Data Core in order to access or download files.
IPD Sharing Time Frame
Research data that documents, supports, and validates research findings and referenced resource from a publication will be made available by on-line publication date unless NIH policy specifies an earlier date.
Learn more about this trial
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
We'll reach out to this number within 24 hrs